Skip to main content
. 2012 Nov 14;2012(11):CD008079. doi: 10.1002/14651858.CD008079.pub2

Analysis 1.6.

Analysis 1.6

Comparison 1 Anti‐leukaemic therapy plus anti‐CD20 versus anti‐leukaemic therapy alone (anti‐leukaemic therapy identical in both groups), Outcome 6 PFS ‐ subgrouped by stage.